Introduction
In 1994, the International Lymphoma Study Group (ILSG), a group of mostly European and American pathologists, proposed a new classification of lymphoid neoplasms [1] . Their approach was an attempt to define diseases which they thought could be recognized with contemporary morphologic, immunologic and genetic techniques. The proposed classification defined nonHodgkin's lymphoma (NHL) subtypes using these techniques, but included no original data on patient characteristics and outcome, or the distribution of the various NHL subtypes.
Thus, in 1995, a group of hematopathologists, clinicians and statisticians were assembled to conduct a retrospective clinical evaluation of the ILSG classification of NHL [2] . The primary focus of this research effort was to evaluate the ability of experienced hematopathologists to apply the ILSG classification to NHL cases collected at various sites around the world and to describe the clinical characteristics and treatment outcomes for the common NHL subtypes. Because the cases came from eight countries on four continents, we were also able to compare the distributions of the major NHL subtypes across geographic regions.
Design
The specific details of the conduct of this study have been published elsewhere [2] . Briefly, nine institutions in eight countries were chosen to participate in the study, in part, because they were thought to have a case base representative of their geographical region. Up to 200 consecutive cases of previously-untreated NHL diagnosed between 1 January 1988 and 31 December 1990 were to be studied at each institution. A tissue biopsy other than bone marrow was required for the diagnosis of NHL. An panel of five review hematopathologists (see Appendix) traveled as a group over a period of eight months to each site and classified each case according to the ILSG classification [1] . In addition, a consensus diagnosis was obtained for each case. The consensus diagnosis was reached when at least four of the five review pathologists agreed upon the ILSG classification. For a diagnosis of follicular lymphoma or peripheral T-cell lymphoma, any grade or subtype was considered an agreement. For cases where consensus could not be reached, additional studies were performed and a consensus diagnosis was assigned based on an agreed upon algorithm.
The chi-square test for contingency tables was used to assess evidence that the distributions of cases among histologic subtypes of NHL differed across geographic areas.
Results
The distribution of cases by histologic subtype for each geographic area is shown in Table 1 . There was strong statistical evidence that the distribution of the cases among the major histologic subtypes of NHL differed substantially by geographic site (P < 0.0001). The distribution across NHL subtypes was similar for Omaha and Vancouver, except that fewer cases of small B-lymphocytic lymphoma were diagnosed in Vancouver. A greater percentage of follicular lymphoma was seen in North America, London and Capetown (28%-32%) than at the other sites (8%-18%). Peripheral T-cell lymphoma made up a larger percentage of the cases from London (8%), Cape Town (8%) and Hong Kong (10%) than from the other sites (l%-6%). Primary mediastinal large B-cell lymphoma accounted for 9% of NHL in Locarno/Bellinzona, whereas at other sites the percentages were 0%-4%. Mantle cell lymphoma was also more common in Locarno/Bellinzona (14%) than at the other sites (l%-8%). Angiocentric nasal T-/NK-cell tumors were only seen in Hong Kong (8%) and Lyon (2%).
Discussion
Previous studies have reported considerable variation in the overall incidence of non-Hodgkin's lymphoma (NHL) worldwide [3, 4] . Differences in the incidence of specific subtypes of NHL have also been reported, but these studies have been hampered by the use of multiple NHL classification systems. As part of a clinical evaluation of the International Lymphoma Study Group (ILSG) classification of NHL, five review hematopathologists reached a consensus diagnosis on 1378 cases of NHL reviewed over an eight month period in eight countries. As a result, we were able to compare the distribution of NHL cases among the common histologic subtypes in different geographic areas. It was not possible to calculate incidence rates because the sizes of the populations from which these cases arose were unknown. Note that the proportion of cases of a particular subtype at a site may be low (high) compared to other geographic sites either because the incidence of that subtype is low (high), or because the incidence is the same but the incidence of the other subtypes in higher (lower). Nevertheless, our findings suggest that some real differences in the incidence of certain subtypes of NHL exist among the geographic sites studied.
The distributions of cases studied in Omaha and Vancouver were similar. There were fewer cases of small lymphocytic lymphoma (SLL) seen in Vancouver, but this was thought to be due to a difference in practice patterns. Vancouver patients diagnosed with chronic lymphocytic leukemia (the leukemic counterpart of SLL) on the basis of a bone marrow biopsy typically would not have had additional biopsies of enlarged lymph nodes performed. Since cases were eligible for this study only if there was a tissue biopsy other than bone marrow available for the diagnosis of NHL, these patients would have been excluded from the study. Similar patients seen in Nebraska and elsewhere were more likely to have had biopsies of enlarged nodes, and would have been included with a diagnosis of SLL with marrow involvement.
Follicular lymphoma was found more frequently in North America, London and Capetown (31% of all cases) than at other geographic sites (14%). Lower rates of follicular lymphoma have been reported in Asian populations [5] and developing countries [6] . The percentage of follicular lymphoma in Hong Kong (8%) was the lowest observed at any study site, and similar to that previously reported for Hong Kong [7] . In a study of the incidence of non-Hodgkin's lymphoma in San Francisco/ Oakland, California and western Washington state, Chinese-Americans and Japanese-Americans both had a reduced risk of follicular lymphoma, and the lowest risks were seen in those born in Asia [8] . The risk of diffuse lymphomas was similar in Chinese-and Japanese-Amer-icans, and US-born whites. In a study of 1391 cases of NHL in patients age 15 years or older who were treated at six major medical centers in four representative areas of Thailand, follicular lymphoma constituted only 3.8% of all cases [9] . Follicular lymphoma also appears to make up only a small minority of cases of NHL seen in Oman (17%) [10] , Pakistan (8%) [11] , Nigeria (13%) [12] and Gabon (2%) [13] . The percentage of follicular lymphoma cases seen in mainland Europe (11%-18%) was also substantially less than that seen in North America, London and Capetown. The reasons for these differences is unknown, but may reflect a true decreased risk of follicular lymphoma among mainland Europeans.
Peripheral T-cell lymphoma represented a greater percentage of the cases in Cape Town (8%), London (8%) and Hong Kong (10%), as compared to the other sites (2%-6%). Indeed, including angiocentric nasal T-/NKcell lymphoma and anaplastic large T-/null-cell lymphoma, T-cell lymphomas comprised 21% of the cases reviewed in Hong Kong. The percentage of T-cell lymphomas in Hong Kong Chinese has been previously reported to be 25% [14] , and the percentage reported in Shanghai is similar (28%) [15] . The increased percentage of T-cell lymphomas observed in Hong Kong is not thought to be related to an increased incidence of T-cell lymphoma, but rather due to a lower incidence of follicular lymphoma [14, 16] . Angiocentric nasal T-/NK-cell lymphoma was only seen in Hong Kong (8%) and Lyon (2%). This tumor is known to have a higher incidence in Asian countries and is associated with a high incidence of Epstein-Barr virus infection [17] ,' as are some peripheral T-cell lymphomas seen in Asia.
Mantle cell lymphoma was more frequently seen in Locarno/Bellinzona, Switzerland (14%) than in the other sites (l%-8%). Few cases of mantle cell lymphoma were seen in Capetown (1%). Interestingly, the National Cancer Institute-sponsored Non-Hodgkin's Lymphoma Pathologic Classification Project also found that mantlecell lymphoma (centrocytic type in the Kiel classification) was much more commonly seen in Milan, Italy (located some 70 miles south of Locarno) than in the American institutions which participated in the project [18] .
One unexpected result of this study was the increased percentage of primary mediastinal large B-cell lymphoma seen in Locarno/Bellinzona, Switzerland. These tumors are indistinguishable from other diffuse large B-cell lymphomas histologically. Nevertheless, they appear to be different clinically, since these patients are younger and more often female than patients with diffuse large B-cell lymphoma [1, 2, 19] . Because of their unusual clinical presentation and their apparent increased percentage in Locarno/Bellinzona, they may have a unique pathogenesis.
In summary, we have shown that the distribution of NHL subtypes differs in different geographical areas around the world, and suggest that these differences may well reflect differences in etiologic factors or the host response to these factors in these geographic areas. Epidemiologic studies focused on specific subtypes of NHL in areas with an increased incidence are needed to elucidate such etiologic factors. 
